Clinical Trials Sponsored by MSI Foundation

Total 16528 results

Northwestern University
OSI Pharmaceuticals

Withdrawn

Erlotinib for Treatment of Psoriasis

Psoriasis

United States
Emory University
OSI Pharmaceuticals

Withdrawn

A Phase I Study of OSI-906 in Combination With Pemetrexed in Advanced Solid Tumor Malignancies

Neoplasms | Cancer | Tumors

United States
MIS Implant Technologies, Ltd

Unknown

Clinical Trial of PeriZone PerioPatch in Subjects With Chronic Periodontitis

Chronic Periodontitis

United States
AdventHealth
MDI Worldwide LLC

Completed

A Comparison of a Sheathed to a Standard Speculum for Visualization of the Cervix

Comparison of a Sheathed Versus Standard Plastic Speculum

United States
Chi Mei Medical Hospital

Completed

Effect of Stellate Ganglion Block on Meniere's Disease

Vertigo | Meniere Disease

Taiwan
Chi Mei Medical Hospital

Completed

Effect of Airway Integrated Nasal Packing With Different Material

Postoperative Respiratory Complications | Pain, Postoperative.

Taiwan
Duke University
Moi University

Not yet recruiting

An Evaluation of a Family Counseling Intervention ("Tuko Pamoja") in Kenya: a Pilot Randomized Controlled Trial (C0058 (4C))

Child Abuse | Parent-Child Relations | Parenting | Child Behavior | Child Mental Disorder | Domestic Violence | Family Relations | Family Conflict | Mental Health Issue | Adolescent - Emotional Problem | Adolescent Problem Behavior | Marital Conflict

Kenya
Moi University
Alexandria University

Completed

Effect of Auditory and Tactile-kinesthetic Stimulation on Preterm Neonates

Prematurity

Kenya
Mai Madkour

Unknown

The Effect of Dexmedetomidine on Kidney Perfusion in Paediatric Patients

Congenital Heart Disease

Egypt
Mayo Clinic
OSI Pharmaceuticals

Completed

Exisulind Versus Placebo After Surgical Removal of the Prostate

Prostatic Neoplasms

United States
Ataturk University
MSc Reyhan YALÇIN; MSc Meral Güven; PhD Adem ASLAN

Completed

The Effects of Manual and Automatic Lancets on Pain and Stress in Newborn Capillary Heel Blood Collection

Pain | Stress | Newborn

Turkey
Texas A&M University
American Psychological Foundation; Psi Chi; Academy for Eating Disorders

Completed

Comparison of a Telehealth Versus In-person Intervention for Binge Eating

Binge Eating

United States
Tanner Foundation for Multiple Sclerosis
Mallinckrodt; Auburn University MRI Research Center; iReportoire Inc

Unknown

Comprehensive Analysis of Relapse in Multiple Sclerosis

Multiple Sclerosis

United States
Universitair Ziekenhuis Brussel
Research Foundation Flanders; National MS Center Melsbroek

Recruiting

Cognitive-motor Telerehabilitation in MS (CoMoTeMS)

Multiple Sclerosis

Belgium
Yong-Mei Cha

Recruiting

His Bundle Pacing in Bradycardia and Heart Failure

Heart Failure | Bradycardia

United States
Nantong University
Chiang Mai University

Completed

Effectiveness of Health Literacy Enhancement Program Among Older Persons With Physical Multimorbidity

Multiple Chronic Conditions；Diabetes；Hypertension

China
Ataturk University
MSc Merve Eroğlu

Completed

The Pain and Anxiety in Children With Intramuscular Injection

Intramuscular Myxoma

Turkey
Ataturk University
MSc İknur Budancamanak

Completed

Peripheral Intravenous Central Catheter Intervention in Preterm Infants

Stress | Pain, Acute | Nursing Caries | Preterm

Turkey
University Hospital, Toulouse
MSD France

Active, not recruiting

COllaboration REsearch on Chronic Cough (COREC): a French Multicenter Database (COREC)

Refractory Chronic Cough

France
University of Oklahoma
OSI Pharmaceuticals

Terminated

Trial of Erlotinib in Patients With JAK-2 V617F Positive Polycythemia Vera (OSI-TAR-766)

Polycythemia Vera

United States
Helsinn Healthcare SA
PSI CRO

Completed

A Safety Study of Intravenous Pro-Netupitant and Palonosetron Combination for the Prevention of Nausea and Vomiting

Chemotherapy-Induced Nausea and Vomiting

Serbia, United States, Israel, Germany, Czechia, Spain, Croatia, Ukraine, South Africa, Austria, Italy, Poland
University Hospital, Caen
MSD France

Unknown

Oral Chemotherapy and Quality of Care (PARCOURS)

Cancer

France
MEI Pharma, Inc.
Quotient Clinical

Completed

Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Various Formulations and Doses of PWT-143

Malignancies

United Kingdom
OSI Pharmaceuticals

Completed

A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors (RADIANT)

Non-small Cell Lung Cancer

United States, Hungary, Spain, Taiwan, Korea, Republic of, Italy, United Kingdom, Canada, Australia, Belgium, Germany, Austria, Poland, Romania, Argentina, France, Czech Republic, Greece, Russian Federation
OSI Pharmaceuticals

Completed

Erlotinib vs. Standard Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) and Eastern Cooperative Oncology Group (ECOG)Performance Status (PS) 2

Non-Small Cell Lung Cancer

United States
OSI Pharmaceuticals

Completed

Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC

Carcinoma, Non-Small-Cell Lung

United States, United Kingdom
OSI Pharmaceuticals

Completed

A Two-Stage Phase 1 Dose Escalation Pharmacokinetic Study of Tarceva in Patients With Stage IIIB/IV Non-small Cell Lung Cancer Who Continue to Smoke After Failure of One or Two Prior Chemotherapy Regimens

NSCLC

United Kingdom, United States
Astellas Pharma Inc
OSI Pharmaceuticals

Completed

Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung Cancer

SCLC | Carcinoma, Small Cell

United Kingdom, United States
Astellas Pharma Inc
OSI Pharmaceuticals

Completed

Study of OSI-211 vs. Topotecan in Patients With Relapsed Epithelial Ovarian Cancer

Ovarian Neoplasms

United Kingdom, United States
Astellas Pharma Inc
OSI Pharmaceuticals

Completed

Study of CP-461 in Patients With Advanced Renal Cell Cancer

Renal Cell Carcinoma

United States
Astellas Pharma Inc
OSI Pharmaceuticals

Completed

Phase 1 Study of OSI-930 in Cancer Patients

Advanced Solid Tumors

United States, United Kingdom
Maharaj Nakorn Chiang Mai Hospital

Not yet recruiting

The Synbiotics Effects in Polycystic Ovary Syndrome: A Randomized Controlled Trial (PCOS)

PCOS- Polycystic Ovary Syndrome

Thailand
MTI University
Ain Shams University

Recruiting

Trends of Acute Intoxication in Poison Control Centre

Poisoning | Poison Drug | Poison;Medicinal;Wrong Drug

Egypt
Chung Mei Biopharma Co., Ltd

Not yet recruiting

Safety and Efficacy of DCB-BO1301 in Advanced Melanoma

Advanced Melanoma
University of Pittsburgh
OSI Pharmaceuticals

Completed

Study of TARCEVA (Erlotinib) as Adjuvant Treatment for Locally Advanced Head and Neck Squamous Cell Carcinoma

Head and Neck Squamous Cell Carcinoma

United States
OSI Pharmaceuticals

Completed

Erlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Cancer

Advanced Pancreatic Cancer

United States
University of Washington
OSI Pharmaceuticals

Completed

Exisulind and Intermittent Androgen Suppression (ADT) in Biochemical Relapsed Prostate Cancer

Prostate Cancer

United States
Abdelwahed, Mai Mahmoud Mohamed, M.D.

Unknown

Bovine Lactoferrin Versus Ferrous Sulphate In The Treatment Of Iron Deficiency Anemia During Pregnancy

Anemia During Pregnancy

Egypt
Helsinn Healthcare SA
PSI CRO

Completed

An Efficacy and Safety Study of Intravenous Palonosetron Administered as an Infusion and as a Bolus for the Prevention of Nausea and Vomiting

Chemotherapy-Induced Nausea and Vomiting

Georgia, Russian Federation, Romania, Hungary, Belarus, Bosnia and Herzegovina, Bulgaria, Greece, Lithuania
University Hospital, Toulouse
MSD France

Completed

Retrospective Efficacy and Safety Study With Elbasvir/Grazoprevir in HCV-infected Patients With Chronic Kidney Disease

Chronic Kidney Diseases | Hepatitis C

France
OSI Pharmaceuticals

Completed

Erlotinib (Tarceva (Trademark), OSI-774) in Treating Patients With Advanced Non-Small Cell Lung Cancer

Advanced Non Small Cell Lung Cancer | Failed Prior Chemotherapy

United States
Mei changlin

Unknown

Radiofrequency Ablation for ADPKD Blood Pressure and Disease Progression Control (RAFALE)

Hypertension | Autosomal Dominant Polycystic Kidney Disease

China
University of Pittsburgh
OSI Pharmaceuticals

Withdrawn

Study of Acitretin to Treat Skin Rash Caused by Erlotinib (a Chemotherapy Drug)

Skin Rash

United States
MTI Medical Private Limited, Pakistan

Unknown

To Study the Efficacy and Safety of Renessans in Chronic HCV Patients

Hepatitis C, Chronic

Pakistan
Astellas Pharma Inc
OSI Pharmaceuticals

Completed

A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients

Non-Small Cell Lung Cancer

United States
Astellas Pharma Inc
OSI Pharmaceuticals

Completed

Phase II Study of Taxotere in Combination With Exisulind in Non-Small Cell Lung Cancer (NSCLC) Patients

NSCLC

United States
Astellas Pharma Inc
OSI Pharmaceuticals

Completed

A Pilot Study of OSI-461 in Patients With Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia

United States
Astellas Pharma Inc
OSI Pharmaceuticals

Completed

Phase I Study of OSI-930 and Erlotinib in Cancer Tumors

Advanced Solid Tumors

United States, United Kingdom
Association De La Msp Pasteur

Not yet recruiting

Feasibility of Integrated Care of Depression in Primary Care Pathways (ESPRI-PSY)

Depressive Disorder
Institut Bergonié
Ipsen; MSD France

Recruiting

Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas (PEMBROCABOSARC)

Osteosarcoma | Ewing Sarcoma | Soft Tissue Sarcoma Adult | Undifferentiated Pleomorphic Sarcoma | Advanced Soft-tissue Sarcoma

France

Clinical Trials Sponsored by MSI Foundation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Italy

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations